Literature DB >> 545425

Psychological factors in the prognosis of malignant melanoma: a prospective study.

G N Rogentine, D P van Kammen, B H Fox, J P Docherty, J E Rosenblatt, S C Boyd, W E Bunney.   

Abstract

Sixty-four patients with Stage I or II malignant melanoma who were apparently disease free rated the amount of adjustment needed to cope with their illness on a scale of 1 to 100. The resultant figure was called the melanoma adjustment score. Twenty-nine patients who relapsed within 1 year of surgery reported a score of 53 +/- 31 (mean +/- SD); 35 nonrelapsers reported a score of 80 +/- 20, p less than 0.001. Based upon analysis of indivual melanoma adjustment scores in the first 31 patients, we predicted that subjects scoring greater or equal to 65 would stay in remission, whereas those scoring greater than 65 would relapse. Applying this prospectively to the next 33 patients we correctly identified 25 of 33 outcomes (76%), p less than 0.03. This psychological variable was independent of known biological prognostic factors, which did not predict 1 year survival. The melanoma adjustment score was also independent of the number of positive lymph nodes, which did correlate with outcome in these patients. The results suggest a role for psychological factors in the one year prognosis of this malignancy.

Entities:  

Mesh:

Year:  1979        PMID: 545425     DOI: 10.1097/00006842-197912000-00006

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  9 in total

1.  Attitudes of cancer: psychometric properties of fighting spirit and denial.

Authors:  D V Nelson; L C Friedman; P E Baer; M Lane; F E Smith
Journal:  J Behav Med       Date:  1989-08

2.  Family attitudes in youth as a possible precursor of cancer among physicians: a search for explanatory mechanisms.

Authors:  J W Shaffer; K R Duszynski; C B Thomas
Journal:  J Behav Med       Date:  1982-06

Review 3.  Influence of psychological coping on survival and recurrence in people with cancer: systematic review.

Authors:  Mark Petticrew; Ruth Bell; Duncan Hunter
Journal:  BMJ       Date:  2002-11-09

4.  Cancer rates after the Three Mile Island nuclear accident and proximity of residence to the plant.

Authors:  M C Hatch; S Wallenstein; J Beyea; J W Nieves; M Susser
Journal:  Am J Public Health       Date:  1991-06       Impact factor: 9.308

5.  The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG).

Authors:  C Hürny; J Bernhard; M Bacchi; B van Wegberg; M Tomamichel; U Spek; A Coates; M Castiglione; A Goldhirsch; H J Senn
Journal:  Support Care Cancer       Date:  1993-07       Impact factor: 3.603

6.  Assessing the needs and quality of life of patients with HIV infection: development of the HIV Overview of Problems-Evaluation System (HOPES).

Authors:  C A Schag; P A Ganz; B Kahn; L Petersen
Journal:  Qual Life Res       Date:  1992-12       Impact factor: 4.147

7.  Melanoma survivorship: research opportunities.

Authors:  Susan A Oliveria; Jennifer L Hay; Alan C Geller; Maureen K Heneghan; Mary S McCabe; Allan C Halpern
Journal:  J Cancer Surviv       Date:  2007-03       Impact factor: 4.442

8.  Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma.

Authors:  J E Brown; P N Butow; G Culjak; A S Coates; S M Dunn
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

Review 9.  Neuroendocrine Factors in Melanoma Pathogenesis.

Authors:  Cristian Scheau; Carmen Draghici; Mihaela Adriana Ilie; Mihai Lupu; Iulia Solomon; Mircea Tampa; Simona Roxana Georgescu; Ana Caruntu; Carolina Constantin; Monica Neagu; Constantin Caruntu
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.